As of 2024-12-12, the Relative Valuation of Corcept Therapeutics Inc (CORT) is 16.17 USD. This relative valuation is based on P/E multiples. With the latest stock price at 60.08 USD, the upside of Corcept Therapeutics Inc based on Relative Valuation is -73.1%.
The range of the Relative Valuation is 9.73 - 21.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 15.7x | 14.2x |
| Forward P/E multiples | 8.4x - 15.1x | 11.4x |
| Fair Price | 9.73 - 21.20 | 16.17 |
| Upside | -83.8% - -64.7% | -73.1% |
| Date | P/E |
| 2024-12-10 | 43.45 |
| 2024-12-09 | 43.78 |
| 2024-12-06 | 44.91 |
| 2024-12-05 | 43.90 |
| 2024-12-04 | 44.96 |
| 2024-12-03 | 44.09 |
| 2024-12-02 | 43.75 |
| 2024-11-29 | 42.62 |
| 2024-11-27 | 43.30 |
| 2024-11-26 | 43.28 |
| 2024-11-25 | 43.61 |
| 2024-11-22 | 42.51 |
| 2024-11-21 | 41.32 |
| 2024-11-20 | 41.44 |
| 2024-11-19 | 40.12 |
| 2024-11-18 | 38.88 |
| 2024-11-15 | 38.29 |
| 2024-11-14 | 40.48 |
| 2024-11-13 | 41.71 |
| 2024-11-12 | 42.70 |
| 2024-11-11 | 43.64 |
| 2024-11-08 | 44.03 |
| 2024-11-07 | 40.12 |
| 2024-11-06 | 40.07 |
| 2024-11-05 | 38.52 |
| 2024-11-04 | 36.99 |
| 2024-11-01 | 35.18 |
| 2024-10-31 | 36.18 |
| 2024-10-30 | 34.64 |
| 2024-10-29 | 35.62 |
| 2024-10-28 | 35.72 |
| 2024-10-25 | 34.93 |
| 2024-10-24 | 34.90 |
| 2024-10-23 | 35.51 |
| 2024-10-22 | 36.14 |
| 2024-10-21 | 36.28 |
| 2024-10-18 | 36.76 |
| 2024-10-17 | 34.85 |
| 2024-10-16 | 34.92 |
| 2024-10-15 | 34.61 |
| 2024-10-14 | 33.47 |
| 2024-10-11 | 33.57 |
| 2024-10-10 | 33.43 |
| 2024-10-09 | 33.94 |
| 2024-10-08 | 33.82 |
| 2024-10-07 | 33.00 |
| 2024-10-04 | 33.57 |
| 2024-10-03 | 33.28 |
| 2024-10-02 | 33.88 |
| 2024-10-01 | 34.54 |